Casandra
Casandra Test Code GE39337Version 1 (DRAFT)
Performing Lab
Lab GeneDxLab Test ID TH01
Nephrolithiasis and Nephrocalcinosis Panel
Clinical Use
Order TestUse
Genetic evaluation of individuals with a history or clinical suspicion of nephrolithiasis or nephrocalcinosis to identify pathogenic variants in genes known to contribute to stone formation or renal calcification.
Special Instructions
Orderable via GeneDx provider portal or requisition menu; associated with test menu code TH01 on the Rare Disorders Test Requisition Form ([genedx.com](https://www.genedx.com/wp-content/uploads/2024/11/67904-Rare-TRF-v241029.pdf?utm_source=openai)).
Limitations
Technical analytical limitations not explicitly stated on provided content. Refer to GeneDx website for up‑to‑date limitations and gene coverage.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Targeted next‑generation sequencing panel for genes associated with nephrolithiasis and nephrocalcinosis, including copy‑number variant analysis.
Result Turnaround Time
14-28 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided